Decomit Plus Inhaler (200 mcg + 6 mcg)/puff is a fixed-dose combination inhaler containing Beclomethasone Dipropionate and Formoterol Fumarate, developed for the long-term management of moderate to severe persistent asthma and other chronic obstructive airway conditions. This higher-strength formulation is intended for patients who require enhanced anti-inflammatory control in addition to sustained bronchodilation.

Beclomethasone Dipropionate is an inhaled corticosteroid that targets airway inflammation, reducing mucosal swelling, inflammatory cell activity, and excessive mucus production. Formoterol Fumarate is a long-acting beta-2 agonist that provides rapid-onset and prolonged relaxation of bronchial smooth muscle, resulting in improved airflow and easier breathing. The combination delivers comprehensive control of airway disease by addressing both inflammation and bronchoconstriction.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Indications

Decomit Plus Inhaler (200 mcg + 6 mcg)/puff is indicated for:

• Maintenance treatment of moderate to severe persistent asthma

• Patients inadequately controlled on lower-dose inhaled corticosteroids or combination therapy

• Long-term management of chronic inflammatory airway diseases

• Reduction in frequency and severity of asthma exacerbations

Dosage and Administration

The dosage should be individualized by a healthcare professional according to disease severity and patient response. The inhaler is commonly used twice daily. It is intended for regular maintenance use and should not be used for immediate relief of acute asthma attacks.

Proper inhalation technique is essential to ensure effective delivery of medication to the lungs. Patients are advised to rinse the mouth with water after each use and spit it out to minimize the risk of oral candidiasis.

Key Benefits

• Higher-dose inhaled corticosteroid for stronger anti-inflammatory control

• Long-acting bronchodilation for sustained symptom relief

• Improves lung function and breathing comfort

• Reduces asthma exacerbations with regular use

• Convenient combination therapy in a single inhaler

Precautions and Warnings

Decomit Plus Inhaler should not be used as a rescue inhaler. A short-acting bronchodilator must be available for sudden symptoms. Caution is required in patients with cardiovascular disease, arrhythmias, hyperthyroidism, or diabetes due to the beta-agonist component.

Long-term use requires periodic medical review. Abrupt discontinuation without medical advice should be avoided.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects include throat irritation, hoarseness, cough, headache, palpitations, tremor, and oral fungal infections. Rinsing the mouth after inhalation significantly reduces local side effects. Rare systemic corticosteroid effects may occur with prolonged high-dose use.

Storage Conditions

Store Decomit Plus Inhaler (200 mcg + 6 mcg)/puff at room temperature, protected from direct sunlight and heat. Do not puncture or expose the canister to high temperatures. Keep out of reach of children.

Decomit Plus Inhaler (200 mcg + 6 mcg)/puff provides advanced, dual-action asthma control for patients requiring higher-dose inhaled corticosteroid therapy combined with long-lasting bronchodilation to maintain optimal respiratory health.